Indian benchmark equity indices, Sensex and Nifty50, opened lower on Thursday, reflecting negative signals from global ...

Nanocap companies-among the lowest in heap-are ranked 1,041 and below in terms of market capitalization. They come after the ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin in 2H 2025 Phase 1 trial in healthy volunteers showed MBX 1416 was generall ...

Shares of Kodiak Sciences KOD have skyrocketed 270.7% in the past six months fueled by updates from the developmental program ...

Our methodology combines sentiment and non-linear analysis, focusing on human behavior patterns to trade stocks like Alcoa ...

Shares of Sarepta Therapeutics SRPT have risen 23% in the past year, significantly outperforming the industry’s 15.7% decline ...

Providing for retirement is the great unifier in the investing world. It is a challenge that all investors face. While ...

It's hardly a challenge to find fast food inside U.S. airports, but two chains are tied with 35 locations each. Can you ...

That's according to a team at HSBC Global Research, led by chief multi-asset strategist Max Kettner. Channeling their inner Kenny Loggins, the HSBC analysts warn that the recent rise in 10-year ...

Kirk Spano shares why the stock market and Bitcoin are the most interesting things to talk about heading into 2025.

And in our call of the day, Cembalest flags a worry as he zeroes in on one recent feat for stocks - the S&P 500 SPX has logged two 20%+ years in a row, which has only happened 10 times since 1871. The ...

Despite the rising competition in the obesity space, we believe that there is room for smaller biotechs like Viking Therapeutics to grab a share of this booming market.